Seattle's NanoString Technologies ($NSTG) stands to make up to $45 million if it can come up with a successful companion diagnostic test to screen for a subset of ...
10X Genomics (NASDAQ:TXG) won a permanent injunction against NanoString Technologies in a patent dispute. 10X Genomics rose 3.3%. A permanent injunction will be issued on Jan. 10, U.S. District Judge ...
* Nanostring technologies-under terms of deal, lam will provide up to $50 million of funding intended to cover costs of development and regulatory approval * Nanostring technologies inc - lam will ...
* NANOSTRING TECHNOLOGIES-TO USE ABOUT $89.0 MILLION OF NET PROCEEDS TO PREPAY AMOUNTS BORROWED, FEES OWING RELATED TO TERMINATION OF SENIOR TERM LOAN FACILITY * NANOSTRING-TO USE ABOUT $89.0 MILLION ...
A top European court ruled against Harvard last week in a patent dispute against biotech company NanoString Technologies, invalidating one of the University’s two disputed patents in three European ...
The results of a UK government consultation on the exhaustion of IP rights and an annual review published by the EPO’s Boards of Appeal were also among the top talking points this week We review ...
The Seattle diagnostic company is scaling one of its products down to make it more widely available to individual researchers, who normally wouldn't be able to afford ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback